Anaspaz en es it fr

Anaspaz Brand names, Anaspaz Analogs

Anaspaz Brand Names Mixture

  • No information avaliable

Anaspaz Chemical_Formula


Anaspaz RX_link

Anaspaz fda sheet

Anaspaz msds (material safety sheet)

Anaspaz Synthesis Reference

Fodor et al., Acta Chem. Acad. Sci. Hung.28(4), 409 (1961)

Anaspaz Molecular Weight

289.369 g/mol

Anaspaz Melting Point


Anaspaz H2O Solubility

3.56 mg/mL

Anaspaz State


Anaspaz LogP


Anaspaz Dosage Forms

Tablets; Oral drops; Elixir; Injection

Anaspaz Indication

For treatment of bladder spasms, peptic ulcer disease, diverticulitis, colic, irritable bowel syndrome, cystitis, and pancreatitis. Also used to treat certain heart conditions, to control the symptoms of Parkinson's disease and rhinitis.

Anaspaz Pharmacology

L-Hyoscyamine, the active optical isomer of atropine (dl-hyoscyamine), is a tertiary amine anticholinergic gastrointestinal agent.

Anaspaz Absorption

Absorbed totally and completely by sublingual administration as well as oral administration.

Anaspaz side effects and Toxicity

Symptoms of overdose include headache, nausea, vomiting, blurred vision, dilated pupils, hot dry skin, dizziness, dryness of the mouth, difficulty in swallowing, and CNS stimulation. LD50=mg/kg(orally in rat)

Anaspaz Patient Information

Anaspaz Organisms Affected

Humans and other mammals